Tomas J. Heyman's Net Worth

$1.14 Million

Estimate Recalculated Jul 2, 2024 05:59PM EST

Who is Tomas J. Heyman?

Tomas J. Heyman has an estimated net worth of $1.14 Million. This is based on reported shares across multiple companies, which include Invivyd, Inc., OptiNose, Inc., Akero Therapeutics, Inc., Xilio Therapeutics, Inc., and EXELIXIS, INC..

SEC CIK

Tomas J. Heyman's CIK is 0001814673

Past Insider Trading and Trends

2023 was Tomas J. Heyman's most active year for acquiring shares with 7 total transactions. Tomas J. Heyman's most active month to acquire stocks was the month of May. 2023 was Tomas J. Heyman's most active year for disposing of shares, totalling 2 transactions. Tomas J. Heyman's most active month to dispose stocks was the month of May. 2023 saw Tomas J. Heyman paying a total of $651,040.00 for 212,229 shares, this is the most they've acquired in one year. In 2023 Tomas J. Heyman cashed out on 52,000 shares for a total of $1,421,529.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Invivyd, Inc. (IVVD) Snapshot price: $4.765

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 23
Form 4
0
0
Jun 22
Form 3
0
0
No matching records found

OptiNose, Inc. (OPTN) Snapshot price: $1.255

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 6
Form 4
0
0
Jun 8
Form 4
0
0
Jun 8
Form 4
0
0
Jun 9
Form 3
0
0
Form 4
0
0
Dec 1
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.76

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 8
Form 4
0
0
Jun 23
Form 4
0
$39.86
-$770,489.20
0
Jun 16
Form 4
0
0
Jun 2
Form 4
0
0
Jun 1
Form 4
0
0
Jun 9
Form 3
0
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.6382

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 12
Form 3
0
0
Form 4
0
0
Sep 15
No matching records found

EXELIXIS, INC. (EXEL) Snapshot price: $20.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+103.64%
18.84K
37.01K
May 31
Form 4
18.18K
18.18K
May 31
Form 3
0
0
No matching records found